DuPont de Nemours, Inc. DD Healthcare & Water Technologies — Research and development expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by DuPont de Nemours, Inc. in its filing.
Tagged under the XBRL concept dd:SegmentResearchAndDevelopmentExpense.
The official record: DuPont de Nemours, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about DuPont de Nemours, Inc.'s healthcare & water technologies — research and development expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is DuPont de Nemours, Inc.'s healthcare & water technologies — research and development expenses?
- DuPont de Nemours, Inc. (DD) reported healthcare & water technologies — research and development expenses of $22M in Q1 2026.
- How has DuPont de Nemours, Inc.'s healthcare & water technologies — research and development expenses changed year-over-year?
- DuPont de Nemours, Inc.'s healthcare & water technologies — research and development expenses increased by 10.0% year-over-year, from $20M to $22M.
- What does healthcare & water technologies — research and development expenses mean?
- Expenditures dedicated to the discovery, development, and improvement of products and technologies within the Healthcare and Water Technologies segment. This investment is essential for maintaining long-term competitiveness and innovation in specialty chemical markets.